Dapagliflozin and Clinical Pharmacist Support for Type 2 Diabetes Management

This study is designed to explore the effects of adding a medication called dapagliflozin and the role of a clinical pharmacist in managing Type 2 Diabetes Mellitus. Participants are adults with diabetes who are already using standard diabetes medications. The study aims to examine whether adding dapagliflozin to their current treatment or having a clinical pharmacist involved in their care can lead to better blood sugar control. This research is important because it may help in finding more effective ways to manage diabetes and improve the health of those affected by it. Participants in this study are divided into three groups. One group receives dapagliflozin along with their regular diabetes medications. Another group receives support from a clinical pharmacist, which includes medication adjustments, dietary advice, education on sticking to their treatment plan, and regular check-ups. The third group continues with their usual diabetes medications without any additional intervention. Over three months, researchers measure changes in blood sugar levels, body weight, and medication compliance. This helps determine how effective each approach is in managing diabetes and improving overall health.